Defining the rules of engagement: B cells, antibodies and cancer control
Cellular & Molecular Immunology, Published online: 06 May 2026; doi:10.1038/s41423-026-01422-xDefining the rules of engagement: B cells, antibodies and cancer control
Cellular & Molecular Immunology
USP21 drives immune evasion in colorectal cancer via deubiquitination and stabilization of β-catenin
Cellular & Molecular Immunology, Published online: 06 May 2026; doi:10.1038/s41423-026-01419-6USP21 drives immune evasion in colorectal cancer via deubiquitination and stabilization of β-catenin
Dual CAR-T cell therapy targeting CD19 and BCMA as a novel opportunity for immune reset in systemic lupus erythematosus
Cellular & Molecular Immunology, Published online: 06 May 2026; doi:10.1038/s41423-026-01403-0Dual CAR-T cell therapy targeting CD19 and BCMA as a novel opportunity for immune reset in systemic lupus erythematosus
De novo engineered disulfide bond supersedes native interchain linkage to enhance TCR pairing and anti-tumor efficacy in T cell therapy
Cellular & Molecular Immunology, Published online: 30 April 2026; doi:10.1038/s41423-026-01418-7De novo engineered disulfide bond supersedes native interchain linkage to enhance TCR pairing and anti-tumor efficacy in T cell therapy
Short-, medium-, versus long-chain fatty acids: mechanisms of immunomodulation and disease pathogenesis
Cellular & Molecular Immunology, Published online: 30 April 2026; doi:10.1038/s41423-026-01412-zShort-, medium-, versus long-chain fatty acids: mechanisms of immunomodulation and disease pathogenesis
De novo engineered disulfide bond supersedes native interchain linkage to enhance TCR pairing and anti-tumor efficacy in T cell therapy
Cellular & Molecular Immunology, Published online: 30 April 2026; doi:10.1038/s41423-026-01418-7De novo engineered disulfide bond supersedes native interchain linkage to enhance TCR pairing and anti-tumor efficacy in T cell therapy
Inhibition of glycosphingolipid synthesis overcomes the steric hindrance of CD30 N-glycans to augment CD30-targeted immunotherapeutic efficacy
Cellular & Molecular Immunology, Published online: 27 April 2026; doi:10.1038/s41423-026-01421-yInhibition of glycosphingolipid synthesis overcomes the steric hindrance of CD30 N-glycans to augment CD30-targeted immunotherapeutic e…
Commentary: Yin and Yang of MAITs in HCC: balancing type 1 vs. type 17 signaling
Cellular & Molecular Immunology, Published online: 24 April 2026; doi:10.1038/s41423-026-01416-9Commentary: Yin and Yang of MAITs in HCC: balancing type 1 vs. type 17 signaling
Interleukin enhancer binding factor 3 exacerbates cardiac inflammation and injury following myocardial infarction by inhibiting Lys48-linked ubiquitination on HNRNPA2B1 in macrophages
Cellular & Molecular Immunology, Published online: 22 April 2026; doi:10.1038/s41423-026-01417-8Interleukin enhancer binding factor 3 exacerbates cardiac inflammation and injury following myocardial infarction by inhibiting Lys48-l…
EZH2 and intracellular Ca<sup>2+</sup> signals interdependently coordinate alloreactive and CAR-T-cell responses
Cellular & Molecular Immunology, Published online: 22 April 2026; doi:10.1038/s41423-026-01413-yEZH2 and intracellular Ca2+ signals interdependently coordinate alloreactive and CAR-T-cell responses